Medline Inc.
- Stock
- Ticker MDLN
- ISIN US58507V1070
- Nasdaq
Medline Inc. has only been trading since 17 Dec 2025. This page shows what the short price history tells, measured from the closing price on the first day with prices. Annualized return, volatility and calendar-year returns follow once a year of prices is available. As of 20 Nov 2026.
Performance since the first day with prices
$10,000 grew to $9,034. Global equities (VT): $10,362.
Daily values from the closing price on the first day with prices, not from an offer price. Excluding taxes and account costs. Dashed: Global equities (VT) for comparison.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 6,644 | 6,886 | 7,115 | – | 7,787 | 7,352 | 7,685 | 7,856 |
| Gross profit | 1,824 | 1,905 | 1,875 | – | 1,914 | 1,841 | 2,215 | 1,925 |
| Operating income | 571 | 642 | 574 | – | 425 | 422 | 395 | 500 |
| EBITDA | 818 | 892 | 827 | – | 686 | 676 | 651 | 759 |
| Net income | 319 | 329 | 318 | 187 | 193 | 239 | 139 | 318 |
| Earnings per share | – | – | – | – | – | 0.16 | 0.07 | 0.22 |
| Balance sheet | ||||||||
| Total assets | – | – | – | – | 38,484 | 39,014 | 39,350 | 40,178 |
| Liabilities | – | – | – | – | 19,198 | 19,665 | 20,273 | 20,792 |
| Equity | – | – | – | – | 10,737 | 11,272 | 11,572 | 11,801 |
| Cash | 840 | 584 | 955 | – | 1,939 | 2,236 | 2,327 | 2,321 |
| Long-term debt | – | – | – | – | 12,484 | 12,495 | 12,548 | 12,551 |
| Cash flow | ||||||||
| Operating cash flow | 682 | 197 | 636 | – | 229 | 412 | 715 | 1,025 |
| Capital expenditure | -98 | -110 | -101 | – | -138 | -96 | -111 | -141 |
| Free cash flow | 584 | 87 | 535 | – | 91 | 316 | 604 | 884 |
Value it:DCF calculatorMultiples calculator
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | $0.22 |
| 5 Aug 2026 | $0.07 |
| 6 May 2026 | $0.16 |
| 25 Feb 2026 | – |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €44bn
- Market cap in trading currency
- $48.8bn
- Enterprise value
- $57.7bn
- P/E
- –
- P/S
- 1.59
- P/B
- 4.13
- EV/Sales
- 1.88
- EV/EBITDA
- 20.8
- Earnings yield
- –
- FCF yield
- 3.9%
Results (last four quarters)
- Revenue
- $30.7bn
- Gross profit
- $7.90bn
- EBITDA
- $2.77bn
- Net income
- $889m
- Earnings per share
- –
- Revenue per share
- $23.31
- Revenue growth
- +10.4%
- Earnings growth
- 0.0%
Profitability
- Gross margin
- 25.7%
- Operating margin
- 5.7%
- Net margin
- 2.9%
- Return on equity
- 7.5%
- Return on assets
- 2.2%
Balance sheet and cash flow
- Cash
- $3.61bn
- Cash per share
- $2.74
- Financial debt
- $12.6bn
- Debt/equity %
- 107
- Current ratio
- 4.04
- Book value per share
- $8.96
- Operating cash flow
- $2.38bn
- Free cash flow
- $1.90bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 1.32bn
- Volume
- 9.29m
- Avg. volume 3 months
- 8.91m
- Relative volume
- 1.0
Price and technicals
- Price
- $37.04
- 1 day
- −2.1%
- 52-week high
- $49.99
- 52-week low
- $31.64
- Distance to 52-week high
- −25.9%
- Distance to 52-week low
- +17.1%
- Distance to 50-day line
- +3.8%
- Distance to 200-day line
- −5.5%
- RSI (14)
- 49
- Volatility 1M
- 73.1%
Performance
- 1 week
- −6.2%
- 1 month
- +6.2%
- 3 months
- +6.7%
- 6 months
- +0.1%
- YTD
- −11.8%
- 1 year
- –
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 26 Sep 2026